Concepedia

Thanigaimalai Pillaiyar

TP

Statistics

Publications

46

Citations

1.6K

H-Index

22

Active since

2010

Affiliations

University of Bonn(Current)

Chungnam National University

University of Tübingen

Chungbuk National University

Tokyo University of Pharmacy and Life Sciences

Thanigaimalai Pillaiyar is an author at University of Bonn specializing in medicinal chemistry, drug discovery, and pharmacology.

ORCID

Publications per year

2010–2025

46

Publications

46

Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors

Julian Breidenbach, Carina Lemke, Thanigaimalai Pillaiyar et al. · Angewandte Chemie International Edition · 2021 · 148 citations · Full text

, , +16

3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents

Sho Konno, Kiyotaka Kobayashi, Miki Senda et al. · Journal of Medicinal Chemistry · 2021 · 129 citations

, , +17

Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice

Clara T. Schoeder, Thanigaimalai Pillaiyar, Burkhard Madea et al. · Forensic Toxicology · 2016 · 127 citations · Full text

, , +13

Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies

Thanigaimalai Pillaiyar, Sho Konno, Takehito Yamamoto et al. · European Journal of Medicinal Chemistry · 2013 · 106 citations · Full text

, , +17

Diindolylmethane Derivatives: Potent Agonists of the Immunostimulatory Orphan G Protein-Coupled Receptor GPR84

Thanigaimalai Pillaiyar, Meryem Köse, Katharina Sylvester et al. · Journal of Medicinal Chemistry · 2017 · 103 citations · Full text

, , +16

1–5 of 46